PSY57 - A COMPARISON BETWEEN ON DEMAND USAGE OF RFVIIA VS PROPHYLAXIS USE OF EMICIZUMAB IN HIGH TITER INHIBITORY HEMOPHILIA A PATIENTS IN IRAN; A COST UTILITY ANALYSIS
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.2633
https://www.valueinhealthjournal.com/article/S1098-3015(18)35935-7/fulltext
Section Title :
Section Order :
1983
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35935-7&doi=10.1016/j.jval.2018.09.2633